NEUROPHARMACOLOGY
Scope & Guideline
Bridging Neuroscience and Pharmacology for Impactful Research
Introduction
Aims and Scopes
- Neuropharmacological Mechanisms:
Researching the biochemical and physiological mechanisms through which drugs affect the nervous system, including receptor interactions and signaling pathways. - Behavioral Pharmacology:
Examining the effects of drugs on behavior and cognition, particularly in relation to addiction, anxiety, depression, and other neuropsychiatric conditions. - Neurodegenerative Disorders:
Investigating pharmacological interventions for conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, focusing on both neuroprotective and restorative strategies. - Developmental Neuropharmacology:
Studying the effects of pharmacological agents during critical periods of development, including prenatal exposure and adolescent drug use. - Innovative Therapeutics:
Exploring novel compounds and treatment strategies, including cannabinoids, psychedelics, and other emerging therapies for various neurological disorders. - Neuroinflammation and Pain:
Researching the role of neuroinflammation in chronic pain conditions and the potential for pharmacological modulation of these pathways. - Translational Research:
Bridging laboratory findings with clinical applications to develop effective therapies for neurological and psychiatric disorders.
Trending and Emerging
- Psychedelics and Mental Health:
Growing interest in the therapeutic potential of psychedelics for treating mental health disorders, including depression and PTSD, is evident in the increasing number of publications. - Cannabinoid Research:
Research exploring the therapeutic applications of cannabinoids in various conditions, including chronic pain, anxiety, and neurodegeneration, is expanding rapidly. - Neuroinflammation and Neuropathic Pain:
There is an increasing focus on understanding the role of neuroinflammation in chronic pain conditions and developing treatments that target these pathways. - Microbiome-Gut-Brain Axis:
Emerging studies exploring the connections between gut microbiota and neurological health, including implications for psychiatric disorders and neuroinflammation. - Personalized Medicine Approaches:
Research emphasizing the need for tailored pharmacological treatments based on genetic, environmental, and individual patient factors is gaining traction. - Neurotechnology and Drug Delivery Systems:
Innovations in drug delivery methods, such as nanotechnology and targeted delivery systems, are becoming a significant focus within the field. - Longitudinal Studies in Neurodevelopment:
There is an increasing trend toward longitudinal studies examining the effects of early-life exposures on long-term neurodevelopmental outcomes.
Declining or Waning
- Traditional Opioid Research:
Research on classic opioids and their mechanisms is becoming less prominent as newer classes of pain medications and non-opioid alternatives gain attention. - Basic Neurotransmitter Studies:
Studies focused solely on neurotransmitter systems without considering the broader context of neuroinflammation and neuroimmune interactions are less frequently published. - Pharmacokinetics of Established Drugs:
There is a noticeable decline in studies centered around the pharmacokinetics of well-established drugs, as the field shifts towards novel compounds and personalized medicine approaches. - Animal Models of Substance Use Disorder:
Research using traditional animal models for substance use disorders is becoming less frequent, with a shift towards more complex models that incorporate social and environmental factors. - Single-Agent Pharmacology:
Research focusing solely on the effects of single agents without considering polypharmacy or combination therapies is waning as the complexity of treatment regimens is recognized.
Similar Journals
BEHAVIOURAL PHARMACOLOGY
Bridging Psychiatry and Pharmacology for Better OutcomesBehavioural Pharmacology is a distinguished academic journal published by Lippincott Williams & Wilkins, focusing on the intricate relationship between pharmacology, psychiatry, and behavioral science. With an ISSN of 0955-8810 and an E-ISSN of 1473-5849, this journal serves as a vital platform for researchers and professionals dedicated to exploring the pharmacological mechanisms underlying behavior and mental health. Operating with a robust track record since its inception in 1992, it has established itself in the academic community, as reflected by its Q3 rankings in both the pharmacology and psychiatry categories for 2023. Additionally, the journal holds a credible position in Scopus rankings, with a percentile ranking indicative of significant contributions to the fields of pharmacology and psychiatry. Aimed at advancing knowledge and disseminating research in the behavioral pharmacology domain, this journal is an essential resource for students, researchers, and clinical professionals seeking to stay at the forefront of this rapidly evolving field. While it is not an open access journal, the rich content and research findings published here continue to foster collaboration and innovation within the community, making it a crucial reference point for current and future studies.
Archives of Neuroscience
Connecting research and therapy for neurological breakthroughs.Archives of Neuroscience is a multidisciplinary journal dedicated to advancing the field of neuroscience through the publication of original research articles, review papers, and case studies. Published by BRIEFLAND, this journal aims to bridge the gap between neuroscience research and clinical applications, fostering a deeper understanding of brain function, neurological disorders, and potential therapeutic approaches. With an ISSN of 2322-3944 and an E-ISSN of 2322-5769, Archives of Neuroscience serves as an essential platform for researchers, professionals, and students alike, encouraging open access to knowledge and insights that drive innovation in the field. Although coverage was discontinued in Scopus from 2016 to 2017, the journal continues to uphold rigorous standards of academic excellence, making it a valuable resource for the neuroscience community seeking to explore and disseminate new findings. The journal is committed to providing timely access to research tools and findings that are crucial for informed decision-making in both academic and clinical settings.
Eneurobiologia
Unlocking the Mysteries of the BrainEneurobiologia is an esteemed open-access journal published by UNIV VERACRUZANA, INST INVESTIGACIONES & EDUCACION, dedicated to advancing research in the vibrant field of neurobiology. With its launch in 2010, the journal aims to disseminate high-quality, peer-reviewed research articles that explore the complexities of neural systems, neurodevelopment, and neurodegenerative disorders. By providing a platform for both established researchers and emerging scholars, Eneurobiologia fosters interdisciplinary collaboration and knowledge exchange within the scientific community. Its open-access model ensures that valuable findings are accessible to a global audience, promoting the widespread application of neurobiological research. As a crucial resource for students, professionals, and researchers alike, Eneurobiologia plays a pivotal role in shaping the future of neurobiological studies and enhancing our understanding of the brain and nervous system.
BMC NEUROSCIENCE
Transforming Neuroscience Research into Open Access InsightsBMC NEUROSCIENCE is a prominent open access journal dedicated to the dissemination of high-quality research within the dynamic and rapidly evolving field of neuroscience. Published by BMC, a well-respected leader in open access publishing, this journal facilitates the free exchange of knowledge since its inception in 2000. With the ISSN 1471-2202, BMC NEUROSCIENCE aims to address the diverse interests of the neuroscience community by covering a broad spectrum of topics, ranging from cellular and molecular neuroscience to general neurological studies, thus appealing to researchers, professionals, and students alike. Although it currently holds a Q4 ranking in Cellular and Molecular Neuroscience and a Q3 rank in miscellaneous Neuroscience categories, its commitment to advancing the understanding of brain function and disorders remains steadfast. The journal features a user-friendly Open Access model, ensuring that critical research findings are readily accessible to everyone, fostering collaboration and innovation in the field. As the journal continues to evolve towards its convergence years of 2024, it aspires to enhance its impact and global reach, making it a valuable resource for anyone interested in advancing neuroscience research.
BRITISH JOURNAL OF PHARMACOLOGY
Advancing pharmacological science for a healthier tomorrow.British Journal of Pharmacology is a premier, peer-reviewed journal published by Wiley, specializing in the dynamic field of pharmacology. With a robust impact factor, this journal ranks in the top quartile (Q1) for pharmacology according to the 2023 category rankings, emphasizing its significance and reputation among the global scientific community. As an essential resource for researchers, professionals, and students alike, the journal provides a platform for innovative research spanning foundational studies to clinical applications in pharmacology, toxicology, and pharmaceutics. Since its inception in 1966, the journal has consistently contributed to the advancement of pharmacological science, fostering a deeper understanding of drug action mechanisms and therapeutic advancements. Although primarily subscription-based, the British Journal of Pharmacology is committed to disseminating high-quality research that shapes the future of the field.
BEHAVIORAL NEUROSCIENCE
Pioneering Research at the Crossroads of Neuroscience and PsychologyBehavioral Neuroscience, published by the American Psychological Association, is a leading academic journal in the field of behavioral neuroscience, which focuses on the biological underpinnings of behavior across various contexts. Established in 1983, this journal has been a vital resource for researchers and professionals seeking to understand the intersection between neural processes and behavioral patterns. With an impressive impact factor that positions it in the Q2 category of Behavioral Neuroscience for 2023, it ranks 58th out of 88 journals in its field, showcasing its significance as a contributor to scientific literature. The journal fosters the dissemination of high-quality research and innovative theories that address critical questions in neuroscience, providing a platform for interdisciplinary collaboration. While it does not offer open access, the extensive distribution through academic libraries ensures wide availability for students, practitioners, and researchers alike. By continuing to publish cutting-edge articles through 2024 and beyond, Behavioral Neuroscience remains essential for those looking to stay at the forefront of advancements in understanding the biological mechanisms of behavior.
MOLECULAR PHARMACOLOGY
Driving Innovation in Pharmacological ResearchMOLECULAR PHARMACOLOGY, published by the American Society for Pharmacology and Experimental Therapeutics, is an influential peer-reviewed journal dedicated to advancing the field of pharmacology through comprehensive research on molecular mechanisms of drug action. With an impressive historic convergence from 1965 to 2024, this journal plays a pivotal role in disseminating high-quality research, showcasing significant findings that impact both clinical and experimental pharmacology. Notably, it holds a distinguished Q1 ranking in Pharmacology and a Q2 ranking in Molecular Medicine as of 2023, reflecting its prominence in the academic community. Researchers and practitioners engaged in pharmacological studies will benefit from the journal’s focus on new therapeutic strategies, drug development, and the molecular basis of drug action. While MOLECULAR PHARMACOLOGY is not an open-access journal, it offers a wealth of knowledge behind a subscription model, ensuring that contributors and readers maintain a high standard of academic rigor. Address all inquiries to the editorial office located at 9650 Rockville Pike, Bethesda, MD 20814-3995, United States.
Neuropeptides
Bridging Research and Clinical ApplicationsNeuropeptides is a prestigious, peer-reviewed journal published by Elsevier, focusing on the critical role of neuropeptides in various biological processes and their implications in cellular and molecular neuroscience, endocrinology, and neurology. With an impact factor reflecting its influence in the field and a diverse audience ranging from researchers to healthcare professionals, the journal serves as an essential platform for the dissemination of groundbreaking research from 1980 to 2024. Adhering to high academic standards, Neuropeptides holds a Q3 ranking in Cellular and Molecular Neuroscience and Endocrine and Autonomic Systems, alongside a solid Q2 ranking in both Endocrinology and Neurology. This positions the journal at the forefront of its disciplines, contributing valuable insights into the understanding of neuropeptide functions in health and disease. By not operating as an Open Access journal, it ensures sustainability in the publishing process while upholding rigorous review standards. Researchers, professionals, and students are encouraged to engage with the findings published in this journal, which plays a vital role in advancing knowledge and fostering collaboration within the neuroscientific community.
BRAIN RESEARCH
Illuminating the complexities of the human brain.BRAIN RESEARCH is a premier journal published by Elsevier, specializing in the intricate domains of neuroscience, developmental biology, and molecular biology. Established in 1966, this esteemed publication has become a cornerstone for researchers, professionals, and students dedicated to advancing our understanding of brain function and disorders. With an impressive impact factor and a consistent presence in the Q2 quartiles across key categories—such as Developmental Biology, Neurology, and Neuroscience—it stands out as an essential resource for disseminating innovative research and pioneering insights. The journal's scope encompasses both clinical and fundamental studies, fostering a multidisciplinary approach to the complexities of neural systems. Although it is not an open-access journal, BRAIN RESEARCH provides a vital platform for sharing progressive findings that can inspire future studies and contribute significantly to the evolutionary discourse in neuroscience. Based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, BRAIN RESEARCH continues to shape the landscape of neuroscience research, inviting submissions that explore the latest discoveries and therapeutic strategies.
Frontiers in Molecular Neuroscience
Pioneering research for a deeper understanding of the brain.Frontiers in Molecular Neuroscience, published by FRONTIERS MEDIA SA, is an esteemed open-access journal dedicated to advancing our understanding of the molecular mechanisms underlying neurological functions and disorders. Since its inception in 2008, the journal has established itself as a reputable source of cutting-edge research, earning a respectable Q2 ranking in both the fields of Cellular and Molecular Neuroscience and Molecular Biology as of 2023. With an ongoing commitment to fostering innovation, the journal presents a platform for researchers, professionals, and students to disseminate their findings and engage in scholarly discourse. The E-ISSN 1662-5099 ensures that research is readily accessible, facilitating the exchange of knowledge crucial to tackling the complexities of neurological conditions. Situated in Switzerland, the journal’s global reach is augmented by its open-access model, allowing for wide dissemination of critical research findings to a diverse audience. Join the vibrant community of scientists and practitioners who are shaping the future of molecular neuroscience through their contributions to this dynamic journal.